USANA Health Sciences (USNA) Tops Q2 EPS by 2c; Boosts FY11 Outlook
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.14 -1.39%
EPS Growth %: +386.7%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +386.7%
Financial Fact:
Income taxes: 6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
USANA Health Sciences (NASDAQ: USNA) reported Q2 EPS of $0.82, $0.02 better than the analyst estimate of $0.80. Revenue for the quarter came in at $148.9 million versus the consensus estimate of $147.33 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.
USANA Health Sciences sees FY2011 EPS of $3.05-$3.10, versus prior guidance of $2.85-$2.95 and the consensus of $3.10. USANA Health Sciences sees FY2011 revenue of $565-$575 million, versus prior guidance of $530-$550 million and the consensus of $583.57 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Intuit holds investor day, reaffirms fiscal 2027 guidance
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
